Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-03-06 @ 10:19 AM
Study NCT ID:
NCT04176393
Status:
COMPLETED
Last Update Posted:
2023-02-13
First Post:
2019-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation
Sponsor:
CStone Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed or Refractory Acute Myeloid Leukemia | View |
Keywords: